Ebracteolata cpd B
CAS No. 83459-37-4
Ebracteolata cpd B( —— )
Catalog No. M31348 CAS No. 83459-37-4
Ebracteolata cpd B is a natural product for research related to life sciences.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 448 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEbracteolata cpd B
-
NoteResearch use only, not for human use.
-
Brief DescriptionEbracteolata cpd B is a natural product for research related to life sciences.
-
DescriptionEbracteolata cpd B is a natural product for research related to life sciences.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number83459-37-4
-
Formula Weight196.2
-
Molecular FormulaC10H12O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Neuromedin U, rat TF...
Neuromedin U, rat TFA is a 23-amino acid brain-gut peptide.
-
Orexin B, human TFA ...
Orexin B, human (TFA) is an endogenous agonist at Orexin receptor with Kis of 420 and 36 nM for OX1 and OX2.
-
Eliglustat hemitartr...
Eliglustat Hemitartrate, with an IC50 of 24 nM, is a specific, potent, oral active glucocerebral glycosidase inhibitor.Eliglustat tartrate shows good potency with an IC50 of 24 nM and specificity against the target enzyme.A novel inhibitor of glucosylceramide synthase (Genz-112638) and assessed its activity in a murine model of Gaucher disease (D409V/null).?Biochemical characterization of Genz-112638 showed good potency (IC(50) approximately 24nM) and specificity against the target enzyme.?
Cart
sales@molnova.com